Explore the latest Lantheus news and information including all current and archived press releases. You can also sign up to receive email alerts.
GE Healthcare and Lantheus Announce Start of a Phase 3 Clinical Trial of Flurpiridaz, an Investigational Agent Being Evaluated for the Detection of Coronary Artery Disease
Lantheus Holdings to Host Second Quarter 2018 Earnings Conference Call on August 1, 2018 at 4:30 p.m. Eastern Time
Lantheus Medical Imaging